Fund Holdings — Euclidean Capital LLC

Total Portfolio Value:
$888.54M
Total Bought:
$415.04M
Total Sold:
$644.6K
Net Transaction:
+$414.40M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
State Street SPDR S&P 500 ETF TrustTR UNIT(SPY)246,250917,141+670,891$105.27M$435.93M49.06%+$330.66M
SPDR Gold SharesGOLD SHS(GLD)1,062,5001,390,000+327,500$182.17M$265.73M29.91%+$83.56M
Ishares TrMSCI INDIA ETF
MSCI INDIA ETF
2,425,1442,425,1440$107.24M$118.37M13.32%+$11.13M
Rapt Therapeutics Inc657,899657,8990$10.93M$16.35M1.84%+$5.41M
Alector Inc1,307,8581,307,8580$8.47M$10.44M1.17%+$1.96M
Foghorn Therapeutics Inc.(FHTX)1,573,7611,573,7610$7.87M$10.15M1.14%+$2.28M
23andme Holding CoCL A10,243,12210,243,1220$10.01M$9.36M1.05%-$657.6K
ORIC Pharmaceuticals, Inc.(ORIC)989,410989,4100$5.99M$9.10M1.02%+$3.12M
PMV Pharmaceuticals, Inc.(PMVP)2,627,6432,627,6430$16.13M$8.15M0.92%-$7.99M
Tenaya Therapeutics, Inc.(TNYA)1,015,7051,015,7050$2.59M$3.29M0.37%+$700.8K
Ngm Biopharmaceuticals Inc992,168992,1680$1.06M$852.3K0.10%-$209.3K
Surrozen, Inc.(SRZN)087,696+87,696$0$824.3K0.09%+$824.3K
Surrozen, Inc.W EXP 08 01 203(SRZN)170,833170,8330$7.0K$3.3K0.00%-$3.7K
SURROZEN INCCOM(SRZN)1,315,4630-1,315,463$644.6K$0—-$644.6K
Page 1 of 1
Euclidean Capital LLC — 13F Holdings — Q4 2023 | TickerTrail